• AHSAN UDDIN Department of Pharmacy, University of Rajshahi, Rajshahi 6205, Bangladesh
  • TRIPTI RANI PAUL Department of Pharmacy, Varendra University, Rajshahi 6204, Bangladesh
  • MONALISA MONWAR Department of Pharmacy, Varendra University, Rajshahi 6204, Bangladesh
  • SHAHIN SARKER Department of Pharmacy, Jashore University of Science and Technology, Jashore 7803, Bangladesh
  • CHAND SULTANA Department of Pharmacy, Mawlana Bhasani Science and Technology University, Tangail 1901, Bangladesh
  • MIR IMAM IBNE WAHED Department of Pharmacy, University of Rajshahi, Rajshahi 6205, Bangladesh


Objective: Aim of the study was to assess drug utilization among pediatric patients in both private practice and hospital settings in Rajshahi city, Bangladesh.

Methods: This observational study was conducted during a period of two months (March to April) in 2017. Prescriptions were randomly collected from patients and recorded in a predesigned questionnaire form. The data analysis was carried out by using a statistical software package GraphPad Prism.

Results: The study involved a total of 185 patients, of which 62.70% were male and 37.30% were female. The patient’s age ranges from 1 mo-12 y and highest number of patients visited physicians belong to group 1 mo-1 y (47.57%). Most commonly occurring disease conditions were pneumonia (24%), the leading cause of hospitalizations among the children's age group of 1 mo-1 y. The results indicated that physician’s handwriting was not clear and legible in 50 (27.03%) prescriptions. A total of 468 drugs were prescribed with an average of 2.53 per prescription. However, none of the drugs were prescribed by generic name. The most commonly prescribed drugs were antibiotics 173 (93.5%). About 78% patients were exposed to antibiotics, of which single antibiotic was prescribed in 116 (62.70%) and two antibiotics in 23 (12.43%) prescriptions. Among the drugs, NSAIDS 65 (35.14%), anti-histamine 57 (30.81%), anti-asthmatic 49 (26.49%) drugs were assigned in prescriptions followed by vitamin and minerals 51 (27.57%). Steroids 57 (30.81%) and hypnotics 26 (14.05%) were also accounted in many prescriptions. Interestingly, antibiotics were indiscriminately prescribed in private practices without any bacteriological examinations, whereas in hospital settings, most of the treatment was initiated after culture and sensitivity tests.

Conclusion: Children were highly exposed to antibiotics, steroids and hypnotics in both private practice and hospital settings.  So Medical practitioners should be aware of current guidelines for prescriptions of antibiotics and drugs in child.

Keywords: Drug utilization, Pediatric, Antibiotic, Steroid, Hypnotics, Polypharmacy


Download data is not yet available.


1. Ginsberg G, Hattis D, Sonawane B, Russ A, Banati P, Kozlak M, et al. Evaluation of child/adult pharmacokinetic differences from a database derived from the therapeutic drug literature. Tox Sci 2002;66:185-200.
2. Takahashi H, Ishikawa S, Nomoto S, Nishigaki Y, Ando F, Kashima T, et al. Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children. Clin Pharmacol Ther 2000;68:541-55.
3. Guyon AB, Barman A, Ahmed JU, Ahmed AU, Alam MS. A baseline survey on the use of drugs at the primary health care level in Bangladesh. Bull World Health Organ 1994;72:265-71.
4. Vallano A, Montane E, Arnau JM, Vidal XC, Pallare, Coll M. Medical specialty and pattern of medicines prescription. Eur J Clin Pharmacol 2004;60:725-30.
5. Ghai OP, Paul VK. Rational drug therapy in pediatric practice. Indian Pediatrics 1988;25:1095-109.
6. Faryna A, Wergowske GL, Goldenberg K. Impact of therapeutic guidelines on antibiotic use by residents in primary care clinics. J General Internal Med 1987;2:102-7.
7. Fedorak RAA, Flamm R, Osato M, Stamler D. Antimicrobial susceptibility of H. pylori in Canada to three key antibiotics: metronidazole, clarithromycin, and amoxicillin. Gastroenterology 1997;112:115.
8. Nahar S, Mukhopadhyay AK, Khan R, Ahmad MM, Datta S, Chattopadhyay S, et al. Antimicrobial susceptibility of Helicobacter pylori strains isolated in Bangladesh. J Clin Microbiol 2004;42:4856-8.
9. Paluck E, Katzenstein D, Frankish CJ, Herbert CP, Milner R, Speert D, et al. Prescribing practices and attitudes toward giving children antibiotics. Can Fam Physician 2001;47:521-7.
10. Andreasen F. Protein binding in plasma from patients with acute renal failure. Acta Pharmacol Toxicol 1973;32:417-29.
11. Hossain MM, Glass RI, Khan MR. Antibiotic use in a rural community in Bangladesh. Int J Epidemiol 1982;11:402-5.
12. Ratanawijitasin S. Drug users in Thailand: identifying problems and developing strategies for rational use of drugs. INRUD News 1996;6:21.
13. WHO. The rational use of drugs. Report of the Conference of Experts. Nairobi, 25-29 November 1985. Geneva, World Health Organization; 1987.
14. Laporte JR, Porta M, Capella D. Drug utilization studies: a tool for determining the effectiveness of drug use. Br J Clin Pharmacol 1983;16:301-4.
15. Tzimis L, Kafatos A. Drug utilization and nutrition patterns among children from indigent and emigrant families in Crete, Greece. Public Health 2000;114:393-7.
16. Hanne M, Morten A, Jesper H. Drug prescribing in Danish children: a population-based study: pharmacoepidemiology and prescription. Eur J Clin Pharmacol 2001;57:159-65.
17. Karande S, Sankhe P, Kulkarni M. Patterns of prescription and drug dispensing. Indian J Pediatrics 2005;72:117-21.
18. Melrose D. Double’ deprivation public and private drug distribution from the perspective of the third world's poor. World Dev 1983;11:181-6.
19. Laporte JR. Towards a healthy use of pharmaceuticals. Deployment Dialogue 1995;2:48-55.
20. Balaji R, Sekkizhar M, Ashok Kumar M, Nirmala P. An observational study of drug utilization pattern and pharmacovigilance of antipsychotics. Int J Curr Pharm Res 2017;9:56-62.
21. Cameron A, Mantel Teeuwisse AK, Leufkens HG, Laing RO. Switching from originator brand medicines to generic equivalents in selected developing countries: how much could be saved? Value Health 2012;15:664–73.
22. Gross F. Drug utilization therapy and practice: the present situation in the federal republic of germany. Eur J Clin Pharmacol 1981;19:387-94.
23. Olsson J, Kimland E, Pettersson S, Odlind V. Pediatric drug use with a focus on off-label prescriptions in swedish outpatient care: a nationwide study. Acta Pediatr 2011;100:1272-5.
24. Sumon Kumar Datta, Tripti Rani Paul, Monalisa Monwar, Ambia Khatun, M Rafiqul Islam, M Ashraf Ali, et al. Patterns of prescription and antibiotic use among outpatients in a tertiary care teaching hospital of Bangladesh. Int J Pharm Pharm Sci 2016;8:60-3.
25. Sridevi SA, Janagan T, Rathnasamy P, Rajarajeswari R. Drug utilization study in the otorhinolaryngology department in a tertiary care hospital. Int J Basic Clin Pharmacol 2013;2:306-10.
26. Padwal SL, Kulkarni MD, Deshmukh VS, Patil JR, Jadhav SS, Jadhav AD. Drug use pattern in the ear, nose, throat outpatient department of a rural tertiary care teaching hospital. Natl J Physiol Pharm Pharmacol 2015;5:212-6.
27. Najmi A, Verma A, Aiman U. Drug utilization study in the outpatient pediatric department of a tertiary care teaching hospital of district Lucknow. Asian J Pharm Clin Res 2015;8:327-30.
28. S KI, Chandy SJ, Jeyaseelan L, Kumar R, Suresh S. Antimicrobial prescription patterns for common acute infections in some rural and urban health facilities of India. Ind J Med Res 2008;128:165-71.
29. Ansari F. Use of systemic anti-infective agents in Iran 1997-1998. Eur J Clin Pharmacol 2001;57:547-51.
30. Mc Gowan JE. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 1983;5:1033-48.
31. Murray BE. Can antibiotic resistance be controlled? N Engl J Med 1994;330:1229-30.
32. Joshi N, Milfred D. The use and misuse of new antibiotics: a perspective. Arch Intern Med 1995;155:569-77.
97 Views | 48 Downloads
How to Cite
UDDIN, A., T. R. PAUL, M. MONWAR, S. SARKER, C. SULTANA, and M. I. I. WAHED. “ASSESSMENT OF DRUG UTILIZATION AMONG PEDIATRIC PATIENTS IN PRIVATE CLINIC AND PUBLIC HOSPITAL OF BANGLADESH”. International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 12, no. 9, July 2020, pp. 54-58, doi:10.22159/ijpps.2020v12i9.29186.
Original Article(s)